Biochemical monitoring definition

Biochemical monitoring means the collection and analy- sis of specimens of body fluids, such as blood or urine, to deter- mine use of licit or illicit drugs.
Sample 1Sample 2Sample 3
Biochemical monitoring means the collection and analysis of specimens of body fluids such as blood or urine to determine use of licit or illicit drugs.
Sample 1Sample 2Sample 3

Examples of Biochemical monitoring in a sentence

  • Biochemical monitoring of lithium treatment, including plasma lithium concentrations, is a standard of care (S); the target range is 0.6-0.8 mmol/l.

  • We aim to accomplish this by addressing critical health care issues and maintaining our focus on delivering affordable, accessible and effective health care.” Id. at 2.

  • Biochemical monitoring of the treatment in paediatric patients with mitochondrial disease.

  • Biochemical monitoring after the initiation of antihypertensive therapy can consequently identify changes related to ADRs before they have caused serious or permanent effects, and so avert them.

  • Biochemical monitoring should be undertaken if there is a reason to believe that there is a likely deficiency based on assessment of nutritional intake and/or clinical condition.

  • Biochemical monitoring after hae- mopoietic stem cell transplant for hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease.

  • Biochemical monitoring of training stress and recovery often involves the use of invasive protocols and costly equipment to measure changes in markers such as salivery testosterone, cortisol and IgA (Neville et al., 2008; Mclellan and Lovell, 2010).

  • The defendant argues that, pursu- ant to the statutory framework governing arbitrations in Connecticut, once an arbitration award is rendered, and the thirty day period for filing an application to vacate, modify or correct the award lapses, a timely application to confirm the award ordinarily must be granted by the court.

  • Biochemical monitoring should continue for a fortnight or until electrolyte parameters are stable.

  • Biochemical monitoring of the early endocytic traffic of the type I interferon receptor.

Related to Biochemical monitoring

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Individual monitoring means the assessment of:

  • Individual monitoring devices means devices designed to be worn by a single individual for the assessment of dose equivalent. For purposes of these regulations, "personnel dosimeter" and "dosimeter" are equivalent terms. Examples of individual monitoring devices are film badges, thermoluminescent dosimeters (TLDs), pocket ionization chambers, optically stimulated luminescence (OSL) dosimeters and personal air sampling devices.

  • Drug therapy management means the review of a drug therapy regimen of a patient by one or more pharmacists for the purpose of evaluating and rendering advice to one or more practitioners regarding adjustment of the regimen.

  • Biochemical Oxygen Demand (BOD) shall mean the quantity of oxygen utilized in the biochemical oxidation of organic matter under standard laboratory procedure in five (5) days at 20 degrees Centigrade, expressed in milligrams per liter.

  • Beam monitoring system means a system designed and installed in the radiation head to detect and measure the radiation present in the useful beam.

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Monitoring means the measurement of radiation, radioactive material concentrations, surface area activities or quantities of radioactive material and the use of the results of these measurements to evaluate potential exposures and doses. For purposes of these regulations, "radiation monitoring" and "radiation protection monitoring" are equivalent terms.

  • Manufacturing means all activities related to the manufacture of a Compound, including planning, purchasing, manufacture, processing, compounding, storage, filling, packaging, waste disposal, labeling, leafleting, testing, quality assurance, sample retention, stability testing, release, dispatch and supply, as applicable.

  • Biological agent shall mean any pathogenic (disease producing) micro-organism(s) and/or biologically produced toxin(s) (including genetically modified organisms and chemically synthesized toxins) which cause illness and/or death in humans, animals or plants.

  • Chemical agent shall mean any compound which, when suitably disseminated, produces incapacitating, damaging or lethal effects on people, animals, plants or material property.

  • Prescription monitoring program “PMP,” or “program” means the program established pursuant to 657—Chapter 37 for the collection and maintenance of PMP information and for the provision of PMP information to authorized individuals.

  • External beam radiation therapy means therapeutic irradiation in which the source of radiation is at a distance from the body.

  • coronavirus means severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Information Technology (IT) System means the combination of hardware components, software, and other equipment to make a system whose core purpose is to accomplish a data processing need such as the automatic acquisition, storage, analysis, evaluation, manipulation, management, movement, control, display, switching, interchange, transmission or reception of data. IT systems include ground systems in support of flight hardware. IT systems do not include—

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • DEVELOPMENTAL SERVICES means therapies, typically provided by a qualified professional using a treatment plan, that are intended to lessen deficiencies in normal age appropriate function. The therapies generally are meant to limit deficiencies related to injury or disease that have been present since birth. This is true even if the deficiency was detected during a later developmental stage. The deficiency may be the result of injury or disease during the developmental period. Developmental services are applied for sustained periods of time to promote acceleration in developmentally related functional capacity. This plan covers developmental services unless specifically listed as not covered.

  • Radionuclide means a radioactive element or a radioactive isotope.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Clean coal technology demonstration project means a project using funds appropriated under the heading “Department of Energy—Clean Coal Technology,” up to a total amount of $2,500,000,000 for commercial demonstration of clean coal technology, or similar projects funded through appropriations for the Environmental Protection Agency. The federal contribution for a qualifying project shall be at least 20 percent of the total cost of the demonstration project.

  • Interchangeable biological product means a biological product that the federal Food and Drug Administration has: